Group 1 - The Chinese Medicine Science and Technology Award for 2025 has been announced, with a project led by Professor Gao Xiaoyan from Beijing University of Chinese Medicine, in collaboration with Tongrentang and six other units, winning the third prize for technological progress [1] - The project focuses on the effective discovery of active substances in traditional Chinese medicine (TCM), which is crucial for establishing a comprehensive quality control standard system for TCM and ensuring the safety and efficacy of clinical applications [2] - The project addresses several technical issues that hinder the comprehensive and accurate discovery of TCM active substances, utilizing advanced techniques such as high-resolution mass spectrometry and metabolomics to enhance the analysis and quantification of TCM efficacy indicators [2] Group 2 - Tongrentang has identified the lack of a quality control system that meets industry needs as a significant pain point and has collaborated with Beijing University of Chinese Medicine to develop proprietary technologies and methods for clarifying active substances and selecting quality control indicators [3] - The collaboration has systematically elucidated the chemical components and metabolic transformations of various TCM herbs, such as rhubarb and ginseng, thereby accurately characterizing the material basis of TCM formulas like Dahuang Zhechong Wan and Ren Shen Yang Rong Wan [3] - Through internal standard enhancements and technological upgrades, the project has further improved product quality, contributing to the overall advancement of TCM quality control [3]

Core Viewpoint - Traditional Chinese medicine (TCM) is becoming an important force in promoting global health, with Tianyao Daren Tang Group actively participating in international cooperation and product innovation to spread TCM benefits beyond borders [1][2]. Group 1: Company Initiatives - Tianyao Daren Tang's flagship product, "Suxiao Jiuxin Wan," was registered as a prescription drug in Russia in 1997, marking it as the first Chinese patent medicine to receive such approval, which set a benchmark for TCM products entering international markets [1]. - Since 2017, Tianyao Daren Tang has established a stable partnership with Russian TCM companies, leading to the registration of various products, including the Dami Wan series and Jing Wan Hong as dietary supplements and cosmetics in Russia [2]. - The company emphasizes not only product export but also the promotion of TCM culture through international exhibitions and academic exchanges, enhancing local understanding and trust in TCM [2]. Group 2: Future Directions - Tianyao Daren Tang aims to deepen cooperation with countries in the Shanghai Cooperation Organization (SCO) in the field of TCM, focusing on clinical research, technology exchange, and mutual recognition of standards to contribute to a global health community [2][3].